Ambrx, CMC Biopharmaceuticals A/S deal

CMC will produce clinical trial quantities of Ambrx's PEGylated recombinant human growth hormone. The preclinical product was developed using Ambrx's ReCode technology. Ambrx expects to file an IND ne...